Font Size: a A A
Keyword [activated clotting time]
Result: 1 - 12 | Page: 1 of 1
1. A Randomized Comparative Study Of The Effects Of Low Molecular Weight Heparin (Fragmin) Or Unfractionated Heparin On Plasma Anti-Xa Activity And Activated Clotting Time During Elective Percutaneous Coronary Intervention
2. The Dose-response Curve Of Heparin Of CHD Patients And The Study Of The Dose Of Heparin Before Cardiopulmonary Bypass(CPB)
3. Influence Of Aprotinin To Activated Clotting Time And Whole Blood Prothrombin Time During Cardiopulmonary Bypass
4. Effect Of Hemocoagulase And Desmopressin On Coagulation Function Of Abdominal Operation Patients
5. Observation And Monitoring Of Low Molecular Weight Heparin On Anticoagulation Therapy After Coronary Artery Bypass Grafting
6. The Effects Of Tirofiban On Platelet Aggression Radio, Activated Clotting Time And Serum Antithrombin Ⅲ In Patients With Acute Coronary Syndrome After Undergoing Percutaneous Coronary Intervention
7. Analysis Of Safety Of Atrial Fibrillation Ablation Under Lower Activated Clotting Times
8. Bivalirudin Is Associated With Better Clinical Outcomes As Opposed To Unfractionated Heparin In Patients Undergoing Primary Percutaneous Coronary Intervention
9. Correlation Between The Changes Of PF4,FDPs,ACT,and Slow Coronary Flow And No Reflow In Patients With STEMI Before And After PCI And Tirofiban
10. Clinical Study Of Reasonable Amount Of Heparin In Patients With Different BMI During PCI Under The Guidance Of ACT
11. The Safety And Its Influencing Factors Of ST-segment Elevation Myocardial Infarction Patients Using Bivalirudin Or Heparin Under Monitoring Activat Ed Clotting Time In Emergency Percutaneous Coronary Intervention
12. A Clinical Study Of Perioperative Coagulation Abnormalities And Individualized Anticoagulation In Children With Congenital Heart Disease
  <<First  <Prev  Next>  Last>>  Jump to